What We Are

Growth-iQ Group is a senior commercial consultancy based in London that works with pharmaceutical and medical technology companies operating in the UK market. The company provides embedded commercial leadership across five service areas: launch excellence and brand refresh, market access and payer engagement, patient access and pathway management, service and community pathway design, and digital health and real-world evidence infrastructure. Growth-iQ operates a hub-and-spoke model, acting as the central strategic partner while integrating specialist delivery partners when required.

Growth-iQ helps pharmaceutical and med-tech companies navigate the commercial, access, and delivery challenges of the UK NHS. This includes building value propositions that translate clinical data into economic language for Integrated Care Boards, designing community care and managed service pathways, running healthcare professional-led patient access and therapy initiation programmes, and developing the digital infrastructure required to capture real-world evidence and demonstrate ongoing value to NHS commissioners.

Patient access and pathway management is a commercial and clinical service model that bridges the gap between a drug receiving NHS approval and patients actually receiving treatment. It involves healthcare professional-led programmes covering therapy initiation, structured patient education, adherence monitoring, and real-world evidence capture. Growth-iQ designs and manages these programmes, deploying specialist nursing resource, digital monitoring tools, and structured follow-up pathways to ensure approved medicines reach eligible patients and remain embedded in NHS clinical workflows.

Growth-iQ supports NHS market access by combining data analytics, direct ICB engagement, and value proposition development. The team works across all 42 Integrated Care Boards in England, using NHS data including Hospital Episode Statistics to identify unmet need, build localised business cases, and facilitate direct relationships with commissioning leads. Growth-iQ does not just produce strategy documents — the team embeds with clients to execute the access journey through to funding and implementation.

The Growth-iQ hub-and-spoke model positions Growth-iQ as the central strategic partner for a client's UK commercial programme. When specific tactical delivery is required, Growth-iQ integrates specialist partner organisations at pre-negotiated rates. This gives clients senior strategic consistency and a single quality-control point, without the administrative burden of managing multiple agency contracts.

Most consultancies produce a strategy and hand it over. Growth-iQ embeds with the client team and executes alongside them. There are no juniors and no handoffs — the same senior specialists who design the strategy are the ones engaging NHS commissioners, building value propositions, and managing patient access programmes. Engagements are structured on a flexible retainer model, meaning clients access the exact seniority and expertise they need without the fixed overhead of a full-time hire.